Free Trial

Penny Stocks To Keep An Eye On - February 2nd

Key Points

  • Fusemachines (FUSE), Aquestive Therapeutics (AQST) and DarkIris (DKI) were identified by MarketBeat’s screener as penny stocks to watch after recording the highest dollar trading volume among penny stocks in recent days.
  • Fusemachines provides AI-as-a-service and machine-learning sales tools, Aquestive is a pharmaceutical firm marketing oral/sublingual film products (e.g., Sympazan, Suboxone, Zuplenz, Azstarys), and DarkIris is a Cayman-incorporated holding company operating through Hong Kong subsidiaries.
  • Penny stocks are typically under $5 and carry elevated risk—characterized by low liquidity, wide bid–ask spreads, and high volatility—making them highly speculative for investors.
  • Five stocks to consider instead of Fusemachines.

Fusemachines, Aquestive Therapeutics, and DarkIris are the three Penny stocks to watch today, according to MarketBeat's stock screener tool. Penny stocks are low-priced shares of very small public companies, typically trading for under $5 per share and often quoted on over-the-counter markets or smaller exchanges. They usually have low liquidity, wide bid–ask spreads and high volatility, making them highly speculative and risk-prone for investors. These companies had the highest dollar trading volume of any Penny stocks within the last several days.

Fusemachines (FUSE)

Fusemachines Inc. develops and delivers artificial intelligence (AI) as a service and machine learning software solutions. The company offers Fuse Anna which is an AI assistant for follow ups through daily reminders; and Fuse Prospector which is an artificial intelligence sales platform. Further, the company offers managed outbound services and AI as a service for big data processing, data management, and cloud analytics.

Read Our Latest Research Report on FUSE

Aquestive Therapeutics (AQST)

Aquestive Therapeutics, Inc. operates as a pharmaceutical company in the United States and internationally. The company markets Sympazan, an oral soluble film formulation of clobazam for the treatment of lennox-gastaut syndrome; Suboxone, a sublingual film formulation of buprenorphine and naloxone for the treatment of opioid dependence; Zuplenz, an oral soluble film formulation of ondansetron for the treatment of nausea and vomiting associated with chemotherapy and post-operative recovery; and Azstarys, a once-daily product for the treatment of attention deficit hyperactivity disorder.

Read Our Latest Research Report on AQST

DarkIris (DKI)

DarkIris Inc. is a holding company incorporated as an exempted company on May 31, 2024 under the laws of the Cayman Islands. We operate substantially all of our business through our subsidiaries in Hong Kong, namely Quantum Arts Co., Limited (“Quantum”) and Hongkong Stellar Wisdom Co., Limited (“Stellar”).

Read Our Latest Research Report on DKI

Recommended Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Fusemachines Right Now?

Before you consider Fusemachines, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Fusemachines wasn't on the list.

While Fusemachines currently has a Sell rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Buy Before SpaceX Goes Public Cover

SpaceX has quietly filed to go public later this year. Ahead of what's expected to be the largest IPO of all time, there are seven space stocks that you can buy today that are positioned to benefit from accelerating space commercialization in 2026.

These seven companies are shaping the next phase of the space economy—from launch leaders and satellite networks to data, defense, and in-space infrastructure.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines